Antifungal Drugs Market to Reach US$ 13,524.2 Mn at a CAGR of 3.2% in 2027 | The Insight Partners

Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection); Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Others); Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others); Dosage form (Drugs, Ointment, Powder, Others) and Geography

Publication Month: Jul 2019 | Report Code: TIPRE00003745 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Published

The global Antifungal Drugs market accounted to US$ 10,182.3 Mn in 2018 and is expected to grow at a CAGR of 3.2% during the forecast period 2019 – 2027, to account to US$ 13,524.2 Mn by 2027.

 

Asia Pacific is the fastest growing geographic market and it is expected to be the fastest revenue contributor throughout the forecast period. Asia Pacific is recognized as a developing market for the pharmaceutical. The growth is driven by that countries such as China, and India which are engaged in conducting several studies.

 

Exhibit: Lucrative Regional Antifungal Drugs Markets

 

Market Insights

Increasing Incidence of Cancers, HIV, and Hospital-Acquired Infections

The incidence of fungal infections due to numerous diseases has increased over the last few decades. Furthermore, bloodstream infection incidence is bimodal, with adult people and premature babies having the maximum risk. Cancer treatment using chemotherapy and radiation causes various changes in the body as they destruct cancer cells. Among the significant difference, one is that this treatment weakens the immune system that increases the chances of getting a fungal infection.

 

Many fungal infections are called opportunistic infections, as they generally affect people with weak immune systems. As HIV weakens the immune system, it is more prone to have some types of fungal infections, like coccidioidomycosis, histoplasmosis, cryptococcosis, and pneumocystis pneumonia (PCP).

 

According to data published by J. Fungi 2017, approximately 3,000,000 cases of chronic pulmonary aspergillosis, around 223,100 cases of cryptococcal meningitis among HIV/AIDs patients. And nearly 700,000 cases of invasive candidiasis, about 250,000 cases of invasive aspergillosis, approximately 100,000 cases of disseminated histoplasmosis, more than 10,000,000 cases of fungal asthma, and around 1,000,000 cases of fungal keratitis occur per annum.

 

Growing Pharmaceutical Industry in Developing Regions

The developing nations are incredibly diverse, and the diseases and health care problems they face are somewhat variable. Thus, the solutions are different and must be made to fit local circumstances. Emerging nations represent an excellent opportunity for the pharmaceutical industry. The emerging markets are expected to be the crucial factor for offering better and lucrative growth opportunities for the market players to expand their business and geographic reach.

 

The treatment for the fungal infections become more straightforward due to the help of the advancement in the technologies. Also, the healthcare expenditure has created lots of opportunities for the developing nations to provide better and more services and facilities to their people. Regions like Asia, the Middle East, and Africa are investing more in the healthcare sectors.

 

According to World Health Organization (WHO), between 2015 and 2020, the pharma sales growth predictions scored higher in developing countries as compared in developed countries, with BRIC-MT (Mexico and Turkey) countries positioning first with a 9.3% growth in sales.

Several factors contribute to the fast growth of pharma emerging markets. The first factor is the patent cliff touching several registered drugs used in the market for several years. Next is the inclination towards the use of generic drugs in established and emerging countries, and the growing availability of biosimilar drugs. The next factor is the change in disease patterns in developing countries. Finally, the difference between manufacturing costs and charges for pharma growth.

 

Infection Type Insights

The global Antifungal Drugs market by infection type segments was led by superficial fungal infection. In 2018, the superficial fungal infection segment held a largest market share of 62.1% of the Antifungal Drugs market, by infection type. Also, the superficial fungal infection segment is expected to be the fastest growing segments of the market in 2027 owing to change in the environmental condition across the globe which is expected to become the major factor for the growth of the Antifungal Drugs market.

 

Exhibit: South and Central America Antifungal Drugs Market, by Infection Type

                     

Strategic Insights

Organic and inorganic growth strategies were observed in global Antifungal Drugs industry. The organic strategies which were conducted more compared to the inorganic strategies for the Antifungal Drugs. For instance, in November, 2017, Merck & Co., Inc. declared that the U.S. Food and Drug Administration (FDA) approved PREVYMIS (letermovir) to be uses as once-daily tablets for oral use and injection for intravenous infusion. Thus, the organic strategy has enabled the company to grow its business in the market.

 

Antifungal Drugs – MARKET SEGMENTATION

 

Global Antifungal Drugs Market – By Infection Type

  • Superficial Fungal Infection
  • Systemic Fungal Infection

Global Antifungal Drugs Market – By Drug Type

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

Global Antifungal Drugs Market – By Therapeutic Indication

  • Aspergillosis  
  • Dermatophytosis
  • Candidiasis
  • Others

Global Antifungal Drugs Market – By Dosage Form

  • Drugs
  • Ointment
  • Powder
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South America (SAM)
    • Brazil
    • Argentina

Company Profiles

  • Pfizer Inc.
  • Sanofi S.A.
  • Gilead Sciences, Inc.
  • Merck And Co., Inc.
  • Scynexis Inc.
  • Novartis International AG
  • Abbott Laboratories
  • Bayer AG
  • Glenmark Pharmaceutical
  • Glaxosmithkline Plc.

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1       Global Antifungal Drugs Market – By Infection Type

1.3.2       Global Antifungal Drugs Market – By Drug Type

1.3.3       Global Antifungal Drugs Market – By Therapeutic Indication

1.3.4       Global Antifungal Drugs Market – By Dosage Form

1.3.5       Global Antifungal Drugs Market – By Geography

2.             Global Antifungal Drugs Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Antifungal Drugs– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1       North America – PEST Analysis

4.2.2       Europe– PEST Analysis

4.2.3       Asia Pacific– PEST Analysis

4.2.4       Middle East and Africa – PEST Analysis

4.2.5       South and Central America – PEST Analysis

4.3       Expert Opinion

5.             Global Antifungal Drugs Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1       Rising Prevalence of Fungal Infections

5.1.2       Increasing Incidence of Cancers, HIV, and Hospital-Acquired Infections

5.1.3       Favourable Government Initiatives to Combat the Antifungal Diseases

5.2       Key Market Restraints

5.2.1       Lack of Awareness Regarding Fungal Infections

5.3       Key Market Opportunities

5.3.1       Growing Pharmaceutical Industry in Developing Regions

5.4       Future Trends

5.4.1       Public-Private Partnerships Agreements in the Pharmaceutical Market

5.5       Impact Analysis of Drivers and Restraints

6.             Antifungal Drugs Market – Global Analysis

6.1       Global Antifungal Drugs Market Revenue Forecasts And Analysis

6.2       Global Antifungal Drugs Market, By Geography - Forecasts And Analysis

6.3       Performance Of Key Players

6.4       Positioning Of Key Players

7.             Antifungal Drugs Market Analysis And Forecasts To 2027   Infection Type

7.1       Overview

7.2       Global Antifungal Drugs Market Share by Infection Type 2018 & 2027 (%)

7.3       Superficial Fungal Infection

7.3.1       Overview

7.3.2       Superficial Fungal Infection Market Revenue and Forecast to 2027 (US$ Mn)

7.4       Systemic Fungal Infection

7.4.1       Overview

7.4.2       Systemic Fungal Infection Market Revenue and Forecast to 2027 (US$ Mn)

8.             Antifungal Drugs Market Analysis And Forecasts To 2027   Drug Type

8.1       Overview

8.2       Global Antifungal Drugs Market Share by Drug Type 2018 & 2027 (%)

8.3       Echinocandins

8.3.1       Overview

8.3.2       Echinocandins Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Azoles

8.4.1       Overview

8.4.2       Azoles Market Revenue and Forecast to 2027 (US$ Mn)

8.5       Polyenes

8.5.1       Overview

8.5.2       Polyenes Market Revenue and Forecast to 2027 (US$ Mn)

8.6       Allylamines

8.6.1       Overview

8.6.2       Allylamines Market Revenue and Forecast to 2027 (US$ Mn)

8.7       Others

8.7.1       Overview

8.7.2       Others Market Revenue and Forecast to 2027 (US$ Mn)

9.             Antifungal Drugs Market Analysis And Forecasts To 2027 – Therapeutic Indication

9.1       Overview

9.2       Global Antifungal Drugs Market Share by Therapeutic Indication 2018 & 2027 (%)

9.3       Aspergillosis

9.3.1       Overview

9.3.2       Aspergillosis Market Revenue and Forecast to 2027 (US$ Mn)

9.4       Dermatophytosis

9.4.1       Overview

9.4.2       Dermatophytosis Market Revenue and Forecast to 2027 (US$ Mn)

9.5       Candidiasis

9.5.1       Overview

9.5.2       Candidiasis Market Revenue and Forecast to 2027 (US$ Mn)

9.6       Others

9.6.1       Overview

9.6.2       Others Market Revenue and Forecast to 2027 (US$ Mn)

10.          Antifungal Drugs Market Analysis And Forecasts To 2027   Dosage Form

10.1    Overview

10.2    Global Antifungal Drugs Market Share by Dosage Form 2018 & 2027 (%)

10.3    Drugs

10.3.1    Overview

10.3.2    Drugs Market Revenue and Forecast to 2027 (US$ Mn)

10.4    Ointment

10.4.1    Overview

10.4.2    Ointment Market Revenue and Forecast to 2027 (US$ Mn)

10.5    Powder

10.5.1    Overview

10.5.2    Powder Market Revenue and Forecast to 2027 (US$ Mn)

10.6    Others

10.6.1    Overview

10.6.2    Others Market Revenue and Forecast to 2027 (US$ Mn)

11.          Antifungal Drugs Market Revenue And Forecasts To 2027   Regional Analysis

11.1    North America Antifungal drugs Market

11.1.1    Overview

11.1.2    North America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)

11.1.3    North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.1.4    North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.1.5    North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication  (US$ Mn)

11.1.6    North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.1.7    North America Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)

11.1.8    US Antifungal Drugs Market

11.1.8.1  US Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.8.2  US Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.1.8.3  US Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.1.8.4  US Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.1.8.5  US Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.1.9    Canada Antifungal Drugs Market

11.1.9.1  Canada Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.9.2  Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.1.9.3  Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.1.9.4  Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.1.9.5  Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.1.10 Mexico Antifungal Drugs Market

11.1.10.1........ Mexico Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.10.2. Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.1.10.3. Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.1.10.4. Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.1.10.5. Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.2    Europe Antifungal Drugs Market

11.2.1    Overview

11.2.2    Europe Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)

11.2.3    Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.2.4    Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.2.5    Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.2.6    Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.2.7    Europe Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)

11.2.8    UK Antifungal Drugs Market

11.2.8.1  UK Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.8.2  UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.2.8.3  UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.2.8.4  UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.2.8.5  UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.2.9    Germany Antifungal Drugs Market

11.2.9.1  Germany Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.9.2  Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.2.9.3  Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.2.9.4  Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.2.9.5  Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.2.10 France Antifungal Drugs Market

11.2.10.1........ France Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.10.2. France Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.2.10.3. France Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.2.10.4. France Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.2.10.5. France Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.2.11 Spain Antifungal Drugs Market

11.2.11.1. Spain Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.11.2... Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.2.11.3... Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.2.11.4... Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.2.11.5... Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.2.12 Italy Antifungal Drugs Market

11.2.12.1.. Italy Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.12.2..... Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.2.12.3..... Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.2.12.4..... Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.2.12.5..... Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.3    Asia Pacific Antifungal Drugs Market

11.3.1    Overview

11.3.2    Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)

11.3.3    Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.3.4    Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.3.5    Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication  (US$ Mn)

11.3.6    Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.3.7    Asia Pacific Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)

11.3.8    China Antifungal Drugs Market

11.3.8.1  China Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.8.2  China Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.3.8.3  China Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.3.8.4  China Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.3.8.5  China Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.3.9    Japan Antifungal Drugs Market

11.3.9.1  Japan Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.9.2  Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.3.9.3  Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.3.9.4  Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.3.9.5  Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.3.10 India Antifungal Drugs Market

11.3.10.1.. India Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.10.2.... India Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.3.10.3.... India Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.3.10.4.... India Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.3.10.5.... India Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.3.11 Australia Antifungal Drugs Market

11.3.11.1..... Australia Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.11.2... Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.3.11.3... Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.3.11.4... Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.3.11.5... Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.3.12 South Korea Antifungal Drugs Market

11.3.12.1........ South Korea Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.12.2....... South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.3.12.3....... South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.3.12.4....... South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.3.12.5....... South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.4    Middle East & Africa Antifungal Drugs Market

11.4.1    Overview

11.4.2    Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)

11.4.3    Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type  (US$ Mn)

11.4.4    Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.4.5    Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.4.6    Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.4.7    Middle East & Africa Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)

11.4.8    UAE Antifungal Drugs Market

11.4.8.1  UAE Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.8.2  UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.4.8.3  UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.4.8.4  UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.4.8.5  UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.4.9    Saudi Arabia Antifungal Drugs Market

11.4.9.1  Saudi Arabia Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.9.2  Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.4.9.3  Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.4.9.4  Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.4.9.5  Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.4.10 South Africa Antifungal Drugs Market

11.4.10.1........ South Africa Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.10.2....... South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.4.10.3....... South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.4.10.4....... South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.4.10.5....... South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.5    South and Central America Antifungal Drugs Market

11.5.1    Overview

11.5.2    South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)

11.5.3    South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.5.4    South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type  (US$ Mn)

11.5.5    South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.5.6    South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.5.7    South and Central America Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)

11.5.8    Brazil Antifungal Drugs Market

11.5.8.1  Brazil Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.8.2  Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.5.8.3  Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.5.8.4  Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.5.8.5  Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

11.5.9    Argentina Antifungal Drugs Market

11.5.9.1  Argentina Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.9.2  Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)

11.5.9.3  Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)

11.5.9.4  Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)

11.5.9.5  Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

12.          Antifungal Drugs Market– Industry Landscape

12.1    Overview

12.2    Comparative Company Analysis

12.3    Growth Strategies Done By The Companies In The Market, (%)

12.4    Recent Development Done By The Companies In The Market (2016-2019)

13.          Antifungal Drugs Market–Key Company Profiles

13.1    Pfizer Inc.

13.1.1    Key Facts

13.1.2    Business Description

13.1.3    Financial Overview

13.1.4    Product Portfolio

13.1.5    SWOT Analysis

13.1.6    Key Developments

13.2    NOVARTIS AG

13.2.1    Key Facts

13.2.2    Business Description

13.2.3    Financial Overview

13.2.4    Product Portfolio

13.2.5    SWOT Analysis

13.2.6    Key Developments

13.3    Merck & Co., Inc.

13.3.1    Key Facts

13.3.2    Business Description

13.3.3    Financial Overview

13.3.4    Product Portfolio

13.3.5    SWOT Analysis

13.3.6    Key Developments

13.4    GlaxoSmithKline plc.

13.4.1    Key Facts

13.4.2    Business Description

13.4.3    Financial Overview

13.4.4    Product Portfolio

13.4.5    SWOT Analysis

13.4.6    Key Developments

13.5    Abbott

13.5.1    Key Facts

13.5.2    Business Description

13.5.3    Financial Overview

13.5.4    Product Portfolio

13.5.5    SWOT Analysis

13.6    BAYER AG

13.6.1    Key Facts

13.6.2    Business Description

13.6.3    Financial Overview

13.6.4    Product Portfolio

13.6.5    SWOT Analysis

13.6.6    Key Developments

13.7    SANOFI S.A

13.7.1    Key Facts

13.7.2    Business Description

13.7.3    Financial Overview

13.7.4    Product portfolio

13.7.5    SWOT ANALYSIS

13.7.6    KEY DEVELOPMENTS

13.8    GILEAD SCIENCES, INC.

13.8.1    Key Facts

13.8.2    Business Description

13.8.3    Financial Overview

13.8.4    Product Portfolio

13.8.5    SWOT Analysis

13.8.6    Key Developments

13.9    SCYNEXIS, Inc.

13.9.1    Key Facts

13.9.2    Business Description

13.9.3    Financial Overview

13.9.4    Product Portfolio

13.9.5    SWOT Analysis

13.9.6    Key Developments

13.10  Glenmark Pharmaceuticals

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Financial Overview

13.10.4 Product Portfolio

13.10.5 SWOT Analysis

13.10.6 Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms


LIST OF TABLES

Table 1.            Country Estimated Burden of Candidaemia

Table 2.            North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 3.            North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 4.            North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 5.            North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 6.            US Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 7.            US Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 8.            US Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 9.            US Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 10.         Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 11.         Canada Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 12.         Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 13.         Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 14.         Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 15.         Mexico Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 16.         Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 17.         Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 18.         Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 19.         Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 20.         Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 21.         Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 22.         UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 23.         UK Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 24.         UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 25.         UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 26.         Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 27.         Germany Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 28.         Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 29.         Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 30.         France Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 31.         France Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 32.         France Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 33.         France Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 34.         Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 35.         Spain Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 36.         Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 37.         Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 38.         Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 39.         Italy Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 40.         Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 41.         Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 42.         Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 43.         Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 44.         Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 45.         Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 46.         China Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 47.         China Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 48.         China Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 49.         China Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 50.         Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 51.         Japan Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 52.         Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 53.         Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 54.         India Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 55.         India Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 56.         India Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 57.         India Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 58.         Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 59.         Australia Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 60.         Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 61.         Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 62.         South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 63.         South Korea Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 64.         South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 65.         South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 66.         Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 67.         Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 68.         Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication  (US$ Mn)

Table 69.         Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 70.         UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 71.         UAE Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 72.         UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 73.         UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 74.         Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 75.         Saudi Arabia Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 76.         Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 77.         Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 78.         South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 79.         South Africa Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 80.         South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 81.         South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 82.         South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type  (US$ Mn)

Table 83.         South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 84.         South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 85.         South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form  (US$ Mn)

Table 86.         Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 87.         Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 88.         Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 89.         Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 90.         Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)

Table 91.         Argentina Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)

Table 92.         Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)

Table 93.         Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)

Table 94.         Recent Development Done By The Companies In The Market

Table 95.         Glossary of Terms, Antifungal Drugs Market

 

LIST OF FIGURES

Figure 1.          Antifungal Drugs Market Segmentation

Figure 2.          Antifungal drugs Segmentation, By Region

Figure 3.          Asia Pacific Antifungal Drugs Market, Revenue (US$ Mn), 2018 & 2027

Figure 4.          Global Antifungal Drugs Market By Infection Type, Market Share (%), 2018

Figure 5.          Global Antifungal Drugs Market By Drug Type, Market Share (%), 2018

Figure 6.          Global Antifungal Drugs Market By Therapeutic Indication, Market Share (%), 2018

Figure 7.          Global Antifungal Drugs Market By Dosage Form, Market Share (%), 2018

Figure 8.          North America PEST Analysis

Figure 9.          Europe PEST Analysis

Figure 10.       Asia pacific PEST Analysis

Figure 11.       Middle East and Africa PEST Analysis

Figure 12.       South and Central America PEST Analysis

Figure 13.       Antifungal Drugs Market Impact Analysis of Drivers and Restraints

Figure 14.       Global Antifungal Drugs Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 15.       Global Antifungal Drugs Market – By Geography Forecasts And Analysis – 2018- 2027

Figure 16.       Market Positioning Of Key Player In Global Antifungal Drugs Market

Figure 17.       Global Antifungal Drugs Market Share by Infection Type 2018 & 2027 (%)

Figure 18.       Superficial Fungal Infection Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Systemic Fungal Infection Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       Global Antifungal Drugs Market Share by Drug Type 2018 & 2027 (%)

Figure 21.       Echinocandins Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       Azoles Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23.       Polyenes Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       Allylamins Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       Global Antifungal Drugs Market Share by Therapeutic Indication 2018 & 2027 (%)

Figure 27.       Aspergillosis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28.       Dermatophytosis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 29.       Candidiasis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 30.       Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 31.       Global Antifungal drugs Market Share by Dosage Form 2018 & 2027 (%)

Figure 32.       Dugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 33.       Ointment Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 34.       Powder Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 35.       Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 36.       North America Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 37.       North America Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 38.       North America Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)

Figure 39.       US Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 40.       Canada Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 41.       Mexico Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 42.       Europe Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 43.       Europe Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 44.       Europe Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)

Figure 45.       UK Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 46.       Germany Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 47.       France Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 48.       Spain Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 49.       Italy Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 50.       Asia Pacific Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 51.       Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 52.       Asia Pacific Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)

Figure 53.       China Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 54.       Japan Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 55.       India Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 56.       Australia Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 57.       South Korea Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 58.       Middle East & Africa Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 59.       Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 60.       Middle East & Africa Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)

Figure 61.       UAE Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 62.       Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 63.       South Africa Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 64.       South And Central America Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 65.       South And Central America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 66.       South and Central America Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)

Figure 67.       Brazil Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 68.       Argentina Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 69.       Comparative Company Analysis

Figure 70.       Growth Strategies Done By The Companies In The Market, (%)

 

The List of Companies

  1. Pfizer Inc.
  2. Sanofi S.A.
  3. Gilead Sciences, Inc.
  4. Merck And Co., Inc.
  5. Scynexis Inc.
  6. Novartis International AG
  7. Abbott Laboratories
  8. Bayer AG
  9. Glenmark Pharmaceutical
  10. Glaxosmithkline Plc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Antifungal Drugs market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global Antifungal Drugs market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.